Cargando…

Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa

BACKGROUND: South Africa has over 6,000,000 HIV infected individuals and the province of KwaZulu-Natal (KZN) is the most severely affected. As public health initiatives to better control the HIV epidemic are implemented, timely, detailed and robust surveillance data are needed to monitor, evaluate a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kharsany, Ayesha BM, Cawood, Cherie, Khanyile, David, Grobler, Anneke, Mckinnon, Lyle R., Samsunder, Natasha, Frohlich, Janet A, Abdool Karim, Quarraisha, Puren, Adrian, Welte, Alex, George, Gavin, Govender, Kaymarlin, Toledo, Carlos, Chipeta, Zawadi, Zembe, Lycias, Glenshaw, Mary T, Madurai, Lorna, M Deyde, Varough, Bere, Alfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654918/
https://www.ncbi.nlm.nih.gov/pubmed/26588902
http://dx.doi.org/10.1186/s12889-015-2179-2
_version_ 1782402126190739456
author Kharsany, Ayesha BM
Cawood, Cherie
Khanyile, David
Grobler, Anneke
Mckinnon, Lyle R.
Samsunder, Natasha
Frohlich, Janet A
Abdool Karim, Quarraisha
Puren, Adrian
Welte, Alex
George, Gavin
Govender, Kaymarlin
Toledo, Carlos
Chipeta, Zawadi
Zembe, Lycias
Glenshaw, Mary T
Madurai, Lorna
M Deyde, Varough
Bere, Alfred
author_facet Kharsany, Ayesha BM
Cawood, Cherie
Khanyile, David
Grobler, Anneke
Mckinnon, Lyle R.
Samsunder, Natasha
Frohlich, Janet A
Abdool Karim, Quarraisha
Puren, Adrian
Welte, Alex
George, Gavin
Govender, Kaymarlin
Toledo, Carlos
Chipeta, Zawadi
Zembe, Lycias
Glenshaw, Mary T
Madurai, Lorna
M Deyde, Varough
Bere, Alfred
author_sort Kharsany, Ayesha BM
collection PubMed
description BACKGROUND: South Africa has over 6,000,000 HIV infected individuals and the province of KwaZulu-Natal (KZN) is the most severely affected. As public health initiatives to better control the HIV epidemic are implemented, timely, detailed and robust surveillance data are needed to monitor, evaluate and inform the programmatic interventions and policies over time. We describe the rationale and design of the HIV Incidence Provincial Surveillance System (HIPSS) to monitor HIV prevalence and incidence. METHODS/DESIGN: The household-based survey will include a sample of men and women from two sub-districts of the uMgungundlovu municipality (Vulindlela and the Greater Edendale) of KZN, South Africa. The study is designed as two sequential cross-sectional surveys of 10,000 randomly selected individuals aged 15–49 years to be conducted one year apart. From the cross sectional surveys, two sequential cohorts of HIV negative individuals aged 15–35 years will be followed-up one year later to measure the primary outcome of HIV incidence. Secondary outcomes include the laboratory measurements for pulmonary tuberculosis, sexually transmitted infections and evaluating tests for estimating population-level HIV incidence. Antiretroviral therapy (ART) access, HIV-1 RNA viral load, and CD4 cell counts in HIV positive individuals will assess the effectiveness of the HIV treatment cascade. Household and individual-level socio-demographic characteristics, exposure to HIV programmatic interventions and risk behaviours will be assessed as predictors of HIV incidence. The incidence rate ratio of the two cohorts will be calculated to quantify the change in HIV incidence between consecutive samples. In anticipation of better availability of population-level HIV prevention and treatment programmes leading to decreases in HIV incidence, the sample size provides 84 % power to detect a reduction of 30 % in the HIV incidence rate between surveys. DISCUSSION: The results from HIPSS will provide critical data regarding HIV prevalence and incidence in this community and will establish whether HIV prevention and treatment efforts in a “real world”, non-trial setting have an impact on HIV incidence at a population level. Importantly, the study design and methods will inform future methods for HIV surveillance.
format Online
Article
Text
id pubmed-4654918
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46549182015-11-22 Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa Kharsany, Ayesha BM Cawood, Cherie Khanyile, David Grobler, Anneke Mckinnon, Lyle R. Samsunder, Natasha Frohlich, Janet A Abdool Karim, Quarraisha Puren, Adrian Welte, Alex George, Gavin Govender, Kaymarlin Toledo, Carlos Chipeta, Zawadi Zembe, Lycias Glenshaw, Mary T Madurai, Lorna M Deyde, Varough Bere, Alfred BMC Public Health Study Protocol BACKGROUND: South Africa has over 6,000,000 HIV infected individuals and the province of KwaZulu-Natal (KZN) is the most severely affected. As public health initiatives to better control the HIV epidemic are implemented, timely, detailed and robust surveillance data are needed to monitor, evaluate and inform the programmatic interventions and policies over time. We describe the rationale and design of the HIV Incidence Provincial Surveillance System (HIPSS) to monitor HIV prevalence and incidence. METHODS/DESIGN: The household-based survey will include a sample of men and women from two sub-districts of the uMgungundlovu municipality (Vulindlela and the Greater Edendale) of KZN, South Africa. The study is designed as two sequential cross-sectional surveys of 10,000 randomly selected individuals aged 15–49 years to be conducted one year apart. From the cross sectional surveys, two sequential cohorts of HIV negative individuals aged 15–35 years will be followed-up one year later to measure the primary outcome of HIV incidence. Secondary outcomes include the laboratory measurements for pulmonary tuberculosis, sexually transmitted infections and evaluating tests for estimating population-level HIV incidence. Antiretroviral therapy (ART) access, HIV-1 RNA viral load, and CD4 cell counts in HIV positive individuals will assess the effectiveness of the HIV treatment cascade. Household and individual-level socio-demographic characteristics, exposure to HIV programmatic interventions and risk behaviours will be assessed as predictors of HIV incidence. The incidence rate ratio of the two cohorts will be calculated to quantify the change in HIV incidence between consecutive samples. In anticipation of better availability of population-level HIV prevention and treatment programmes leading to decreases in HIV incidence, the sample size provides 84 % power to detect a reduction of 30 % in the HIV incidence rate between surveys. DISCUSSION: The results from HIPSS will provide critical data regarding HIV prevalence and incidence in this community and will establish whether HIV prevention and treatment efforts in a “real world”, non-trial setting have an impact on HIV incidence at a population level. Importantly, the study design and methods will inform future methods for HIV surveillance. BioMed Central 2015-11-20 /pmc/articles/PMC4654918/ /pubmed/26588902 http://dx.doi.org/10.1186/s12889-015-2179-2 Text en © Kharsany et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Kharsany, Ayesha BM
Cawood, Cherie
Khanyile, David
Grobler, Anneke
Mckinnon, Lyle R.
Samsunder, Natasha
Frohlich, Janet A
Abdool Karim, Quarraisha
Puren, Adrian
Welte, Alex
George, Gavin
Govender, Kaymarlin
Toledo, Carlos
Chipeta, Zawadi
Zembe, Lycias
Glenshaw, Mary T
Madurai, Lorna
M Deyde, Varough
Bere, Alfred
Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa
title Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa
title_full Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa
title_fullStr Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa
title_full_unstemmed Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa
title_short Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa
title_sort strengthening hiv surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor hiv prevalence and incidence in the umgungundlovu district, kwazulu-natal, south africa
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654918/
https://www.ncbi.nlm.nih.gov/pubmed/26588902
http://dx.doi.org/10.1186/s12889-015-2179-2
work_keys_str_mv AT kharsanyayeshabm strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica
AT cawoodcherie strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica
AT khanyiledavid strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica
AT grobleranneke strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica
AT mckinnonlyler strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica
AT samsundernatasha strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica
AT frohlichjaneta strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica
AT abdoolkarimquarraisha strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica
AT purenadrian strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica
AT weltealex strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica
AT georgegavin strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica
AT govenderkaymarlin strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica
AT toledocarlos strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica
AT chipetazawadi strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica
AT zembelycias strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica
AT glenshawmaryt strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica
AT madurailorna strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica
AT mdeydevarough strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica
AT berealfred strengtheninghivsurveillanceintheantiretroviraltherapyerarationaleanddesignofalongitudinalstudytomonitorhivprevalenceandincidenceintheumgungundlovudistrictkwazulunatalsouthafrica